在贝希特病中神经学参与的表现和预测因素
Margarida Lucas Rocha1, Roberto Pereira da Costa2, Ana Teodósio Chícharo1
1Unidade Local de Saúde do Algarve, Faro, Portugal.
患有中枢神经系统 (神经神经系统) 干扰的贝切特病患者更有可能非白种人,并患有生殖器或眼部问题. 由于Neuro-BD的高死亡率,对这些预测因素的早期识别至关重要.
科学领域:
- 神经学 神经学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 贝切特病 (BD) 是一种多系统性炎症性疾病.
- 中枢神经系统 (CNS) 的参与,或神经-BD (NBD),是一种严重并发症,患病率可变 (1-59%).
研究的目的:
- 为了描述中枢神经系统受影响的BD患者.
- 为了确定神经 BD 的预测因子.
主要方法:
- 对157名BD患者进行了回顾性观察研究 (2014年10月 - 2023年5月).
- 收集关于人口统计,临床特征和治疗方法的数据.
- 基于国际共识推标准的NBD诊断.
主要成果:
- 15%的BD患者患有NBD,主要是帕伦基马性.
- NBD患者更有可能非高加索人,在发病时出现生殖器 (68%vs34%),以及眼部表现 (58%vs35%).
- NBD与较高的死亡率 (13%对2%) 和增加使用免疫抑制剂 (如环胺) 相关.
结论:
- 发病时的生殖器和眼部表现是NBD的独立预测因素.
- 由于NBD的严重程度和高死亡率,迅速识别NBD至关重要.
- 识别高风险患者可以指导早期干预策略.
更多相关视频
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
相关概念视频
Endocarditis II: Clinical Features of Infective Endocarditis
Chronic Kidney Disease II: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
